BioSpace News Archive

Press Releases

Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2026 Financial Results; Highlights Multiple Milestones Advancing Broad, Diverse Pipeline

October 29, 2026
·
19 min read
Press Releases

Bristol Myers Squibb Reports Third Quarter Financial Results for 2026

October 29, 2026
·
1 min read
Press Releases

Omnicell Announces Third Quarter 2026 Financial Results

October 29, 2026
·
20 min read
Press Releases

Ocugen to Participate in Upcoming November 2026 Investor and Industry Conferences

October 29, 2026
·
2 min read
Press Releases

Junshi Biosciences Announces the Completion of First Patient Dosing in the Phase 3 Clinical Trial of JS207 in Combination with JS007 for the First-Line Treatment of Advanced Hepatocellular Carcinoma

October 29, 2026
·
5 min read
Press Releases

Kymera Therapeutics Announces Third Quarter 2026 Financial Results and Reports Positive Results from the KT-579 Phase 1 Healthy Volunteer Trial

October 29, 2026
·
13 min read
Press Releases

Minerva Neurosciences to Participate in 2026 Jefferies Global Healthcare Conference in London

October 29, 2026
·
1 min read
Press Releases

Ligand Reports Third Quarter 2026 Financial Results

October 29, 2026
·
31 min read
Press Releases

C4 Therapeutics Unveils Expansion of Discovery Platform Capabilities Utilizing Target-Centric Approach to Accelerate the Identification of Novel Molecular Glue Degraders

October 29, 2026
·
5 min read
Press Releases

BioCryst to Present New Data for ORLADEYO® (berotralstat) and Navenibart at the 2026 American College of Allergy, Asthma & Immunology Annual Scientific Meeting

October 29, 2026
·
7 min read